Latham & Watkins represented Zentalis Pharmaceuticals in the transaction. Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological […]
Pfizer’s $25 Million Equity Investment in Zentalis Pharmaceuticals
Hasbro’s $146.3 Million Acquisition of D&D Beyond
Latham & Watkins represented Fandom in the transaction. Hasbro, Inc. (NASDAQ: HAS) has announced that it is acquiring D&D Beyond, the leading digital toolset and game companion […]
Carlyle and PAI Partners’ Acquisition of Theramex
Linklaters and Allen & Overy advised global investment firms Carlyle and PAI Partners, while Latham & Watkins acted for CVC Capital Partners and Theramex. Taylor Wessing […]
DigitalOcean’s $1.5 Billion Convertible Senior Notes Offering
Latham & Watkins represented the initial purchasers in the offering. DigitalOcean Holdings, Inc. finalized its offering of US$1.5 billion aggregate principal amount of 0% convertible senior notes […]
GTCR’s Acquisition of Cisive
Latham & Watkins represented GTCR in the transaction, while Willkie Farr & Gallagher represented Cisive. GTCR, a leading private equity firm, has signed a definitive agreement to […]
Novo Holdings’ Acquisition Of BBI Group
Allen & Overy advised Exponent Private Equity on the deal. Kromann Reumert and Latham & Watkins assisted Novo Holdings. White & Case advised Goldman Sachs, Golub […]